CVS Health Corp


Want a discount? Become a member by purchasing Annual Subscription!
SKU: CVS Category:


CVS Health is an integrated health care services provider and also a classic example of a financially robust giant trading at low valuations. The company has played a key role in Operation Warp Speed with respect to the delivery of COVID-19 vaccines to U.S. citizens. The new CEO Karen Lynch, who has taken over from Larry Merlo from February, 2021 is expected to continue the company’s growth story as the 2021 guidance of CVS Health looks very promising. Retail and long-term care are strong drivers for growth but the stock trades at a heavy conglomerate discount which is why we maintain our ‘Outperform’ rating on the company and revise the target price.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $496 annual subscription!